Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

The global antidepressants market size is projected to reach USD 18.29 billion by 2027, exhibiting a CAGR of 2.9% during the forecast period. The skyrocketing demand for depression management drugs amid the COVID-19 pandemic will rapidly broaden the horizons of this market, observes Fortune Business Insights™

Click here to get the short-term and long-term impacts of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/antidepressants-market-105017

List of Key Companies Covered in this Market Report:

  • Teva Pharmaceutical Industries Ltd. (Petah Tikva, Israel)

  • AstraZeneca (Cambridge, U.K)

  • Pfizer Inc. (New York, U.S)

  • Eli Lilly and Company (Indiana, U.S)

  • H. Lundbeck A/S (Denmark, Europe)

  • Bristol-Myers Squibb (New York, U.S)

  • Merck & Co. Inc. (New Jersey, U.S)

  • Janssen Pharmaceuticals (Beerse, Belgium)

  • GlaxoSmithKline plc (Brentford, U.K)

Some major points from Table of Content:

  • Introduction

    • Market Scope

    • Market Segmentation

    • Market Methodology

    • Definitions and Assumptions

  • Executive Summary

  • Market Dynamics

    • Market Drivers

    • Market Restraints

    • Market Opportunities

  • Key Insights

    • Prevalence of Anxiety & Depression –Key Regions/Country

    • New Product Launch

    • Pipeline Analysis

    • Impact of COVID-19 on the Market

    • Key Industry Developments – Mergers, Acquisitions, and Partnerships

  • Global Antidepressants Market Analysis, Insights and Forecast, 2016-2027

    • Key Findings / Summary

    • Market Analysis, Insights and Forecast – By Drug Class

      •  Selective Serotonin Reuptake Inhibitors (SSRIs)

      •  Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)

      •  Atypical Antidepressants

      •  Tricyclic Antidepressants (TCAs)

      •  Monoamine Oxidase Inhibitors (MAOIs)

      •  Others

    • Market Analysis, Insights and Forecast – By Disorder

      •  Major Depressive Disorder

      •  Obsessive Compulsive Disorder

      •  Generalized Anxiety Disorder

      •   Panic Disorder

      •   Others

    • Market Analysis, Insights and Forecast – By Distribution Channel

      •  Hospital Pharmacy

      •  Retail Pharmacy

      •  Online Pharmacy

    • Market Analysis, Insights and Forecast – By Geography

      •  North America

      •  Europe

      •  Asia Pacific

      •  Latin America

      •  Middle East & Africa

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe